Breaking News Instant updates and real-time market news.

IRWD

Ironwood

$14.12

0.03 (0.21%)

08:21
11/06/18
11/06
08:21
11/06/18
08:21

Ironwood expects total restructuring costs approx. $16M

Ironwood continues to expect in 2018: SG&A expenses to be in the range of $230M to $250M; R&D expenses to be in the range of $160M to $180M; the combined Ironwood and Allergan total marketing and sales expenses for LINZESS to be in the range of $230M to $260M; and, net interest expense to be less than $40M. Ironwood now expects total restructuring costs to be approximately $16M, versus previous guidance of $18M to $21M.

  • 06

    Nov

  • 12

    Nov

IRWD Ironwood
$14.12

0.03 (0.21%)

10/31/18
WELS
10/31/18
NO CHANGE
Target $18.5
WELS
Outperform
Ironwood price target lowered to $18.50 from $23 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target on Ironwood (IRWD) to $18.50 after the Allergan (AGN) Q3 results lowered expectations for their jointly produced Linzess product. The analyst notes that the management of Ironwood also subsequently confirmed its base case sales growth of low single digits, also lowering his FY19 EPS view to 63c from 69c. Longer term, Maris keeps his Outperform rating, saying the recent share decline should make the board revisit its strategic review and question whether the company is better off being independent.
10/31/18
HCWC
10/31/18
NO CHANGE
Target $12.5
HCWC
Sell
H.C. Wainwright backs Sell rating on Ironwood with Linzess seen disappointing
H.C. Wainwright analyst Raghuram Selvaraju reiterated his Sell rating on shares of Ironwood Pharmaceuticals (IRWD) after partner Allergan (AGN) indicated with its quarterly earnings report that it expects future revenue growth for Linzess to be in the low- to mid-single digits. He also believes that Ironwood's own financials for the third quarter may prove even more disappointing due to the company's history of poor operational expense control, Selvaraju added. He keeps a $12.50 price target on Ironwood shares ahead of its quarterly report, due on November 6.
10/31/18
MZHO
10/31/18
NO CHANGE
Target $23
MZHO
Buy
Ironwood 18% selloff yesterday overdone, says Mizuho
Ironwood Pharmaceuticals (IRWD) sold off 18% yesterday on Allergan's ((AGN) "unexpectedly muted outlook" for Linzess' growth, Mizuho analyst Irina Koffler tells investors in a research note. The analyst views Ironwood as oversold and reiterates a Buy rating on the shares. She did, however, lower her price target for the stock to $23 from $27 on a reduced Linzess forecast and a zero value for the R&D company spin off.
09/17/18
HCWC
09/17/18
NO CHANGE
Target $12.5
HCWC
Sell
H.C. Wainwright reiterates Sell rating on Ironwood despite Fast Track
H.C. Wainwright analyst Raghuram Selvaraju reiterates a Sell rating on Ironwood Pharmaceuticals after the FDA granted mid-stage clinical candidate praliciguat Fast Track Designation for the treatment of patients with heart failure with preserved ejection fraction. The analyst says the Fast Track designation does not change his viewpoint regarding praliciguat, which he believes is a "risky proposition at best." Selvaraju keeps a $12.50 price target for Ironwood shares.

TODAY'S FREE FLY STORIES

PENN

Penn National

$19.76

-0.3 (-1.50%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Recommendations
Penn National analyst commentary  »

Penn National added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Earnings
Meritor sees FY19 adj. EPS about $3.10, consensus $3.32 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

LLY

Eli Lilly

$111.85

-0.77 (-0.68%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Hot Stocks
Eli Lilly submits NDA for lasmiditan, gets breakthrough designation for Emgality »

Eli Lilly has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

06:50
11/14/18
11/14
06:50
11/14/18
06:50
General news
European stock markets pared some of their losses »

European stock markets…

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Canada Goose raises FY19 adj. EPS growth view to at least 25% from at least 40% »

Consensus for FY19 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SGMO

Sangamo

$10.80

0.8 (8.00%)

, BMRN

BioMarin

$93.51

0.43 (0.46%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Downgrade
Sangamo, BioMarin, Spark Therapeutics rating change  »

JPMorgan downgrades…

SGMO

Sangamo

$10.80

0.8 (8.00%)

BMRN

BioMarin

$93.51

0.43 (0.46%)

ONCE

Spark Therapeutics

$42.74

1.12 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Meritor reports Q4 adj. EPS 82c, consensus 71c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

MRK

Merck

$74.62

-0.06 (-0.08%)

06:48
11/14/18
11/14
06:48
11/14/18
06:48
Hot Stocks
Merck: Phase 3 KEYNOTE-181 trial met a primary endpoint of overall survival »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 11

    Jan

  • 16

    Feb

WFC

Wells Fargo

$52.74

0.38 (0.73%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Periodicals
Departure of top Wells Fargo exec Hardison shows rift with regulator, WSJ says »

Hope Hardison, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

TRU

TransUnion

$64.43

-0.41 (-0.63%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Hot Stocks
TransUnion CEO James Peck to retire, Chris Cartwright to succeed »

TransUnion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Earnings
Canada Goose reports Q2 adjusted EPS 46c, consensus (7c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

, GIS

General Mills

$45.50

-0.2 (-0.44%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Downgrade
Kellogg, General Mills, Kraft Heinz rating change  »

JPMorgan downgrades…

K

Kellogg

$63.48

-0.81 (-1.26%)

GIS

General Mills

$45.50

-0.2 (-0.44%)

KHC

Kraft Heinz

$53.38

-0.29 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

06:45
11/14/18
11/14
06:45
11/14/18
06:45
General news
Breaking General news story  »

Week of 11/9 MBA Mortgage…

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

06:40
11/14/18
11/14
06:40
11/14/18
06:40
Downgrade
Jounce Therapeutics rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Periodicals
Amazon says over 10,000 workers are developing Alexa, Echo, WSJ reports »

Amazon has over 10,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

NOVN

Novan

$2.50

-0.04 (-1.57%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Hot Stocks
Novan Phase 2 molluscum contagiosum trial achieves statistical significance »

Novan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

LLESY

Lendlease Group

$0.00

(0.00%)

06:37
11/14/18
11/14
06:37
11/14/18
06:37
Upgrade
Lendlease Group rating change  »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.47

-0.03 (-0.14%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Syndicate
VICI Properties files to sell 25M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Earnings
Hollysys reports Q1 adjusted EPS 46c vs. 36c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Earnings
Astronics sees FY19 Aerospace revenue $710M-$745M »

"In our third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Upgrade
Hollysys rating change  »

Hollysys upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

, GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

06:34
11/14/18
11/14
06:34
11/14/18
06:34
Periodicals
Google to double New York City staff over next ten years, WSJ reports »

Google (GOOGL) has plans…

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Zymeworks updates clinical data for ZW25 anti-tumor candidate »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Astronics sells semiconductor test business to Advantest for $185M in cash »

Astronics announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SNAP

Snap

$6.72

0.06 (0.90%)

, FB

Facebook

$142.19

0.67 (0.47%)

06:32
11/14/18
11/14
06:32
11/14/18
06:32
Periodicals
Snap subpoenaed by DOJ, SEC over IPO disclosures, Reuters reports »

The U.S. Justice…

SNAP

Snap

$6.72

0.06 (0.90%)

FB

Facebook

$142.19

0.67 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.